#gynonc at @OHSUKnight. Views are mine; no COIs.
Portland, OR
Joined November 2009
- Tweets2.4K
- Following759
- Followers1K
- Likes1.6K
Ross Harrison, MD MPH retweeted
Today at the @RivkinCenter AACR Ovarian Cancer Research Symposium Moffitt’s Karen Lu, MD (@karenluMD) co-chairs the Prevention, Early Detection, & Interception session. Check out her video to learn more!
⏰: 9/20 -4:50 p.m. PDT
📍: Washington Ballroom
Learn more ➡️ bit.ly/47E4WlK
Ross Harrison, MD MPH retweeted
Excited to represent @SGO_org @GYNCancer as Social Media Ambassador for our 2025 Annual #SGOMtg! ⏰ Abstract submission deadline is approaching quickly Sept 27th! We will Multiply Your Impact through our exciting program and social media!💥Join us in Seattle! #AM25IMPACT #gyncsm
Remember the incredible abstracts presented at the SGO 2024 Annual Meeting on Women’s Cancer?
If you're interested in presenting in 2025, SGO is now accepting abstract and surgical film submissions for the 2025 Annual Meeting. #SGOMtg #AM25IMPACT
Submit: sgo.org/events/annual-meetin…
Ross Harrison, MD MPH retweeted
People with advanced #EndometrialCancer now have new FDA-approved treatment options: pembrolizumab and durvalumab, paired with chemotherapy, for tumors with a genetic change called mismatch repair deficiency. go.nih.gov/Qmz5ojG
ALT A depiction of immune cells attacking cancer cells.
Ross Harrison, MD MPH retweeted
Rates of new #UterineCancer cases increased by 0.7% each year from 2012 to 2021. The death rate from uterine cancer increased by 1.5% each year from 2013 to 2022. Visit our Cancer Stat Facts sheet to learn more: buff.ly/2YXE2S4 #GynCSM
Ross Harrison, MD MPH retweeted
From medical enigma to a roadmap for recovery, one @OHSUNews patient's life-altering journey through a rare skin, musculature condition and stage 3 cancer.
This is Kathy's remarkable story: bit.ly/4b2Exhx
Ross Harrison, MD MPH retweeted
#Small bite fascial closure reduces #incisional hernia rates in #GynOncology patients by @uppals @astraubhar
📄 bit.ly/45hpH5D
@umichMedicine @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
Ross Harrison, MD MPH retweeted
The rate of new #OvarianCancer cases fell by 2.7% each year from 2012 – 2021 and the death rate fell by 2.4% each year from 2013 – 2022. Visit our Cancer Stat Facts sheet to learn more: buff.ly/2ITyl21 #GynCSM #WorldOvarianCancerDay
Ross Harrison, MD MPH retweeted
Ever wonder why your insurer charges a copay for statins (and other high-value meds)?
Don’t they want to prevent heart attacks, strokes, etc?
Copays never made sense to me.
In this new paper in @QJEHarvard, we show copays kill. 🧵
tinyurl.com/nhk4v93f
Ross Harrison, MD MPH retweeted
Dear members of @sgo, a question came up during our journal club and I cannot find the answer. Can someone please help?
Why did investigators in the RUBY trial pick 3 years of Dostarlimab maintenance? Is there a biologic explanation? @matthewapowell #endometrialcancer
Ross Harrison, MD MPH retweeted
So excited to be in Mozambique with @NCICastle collaborating with @CISPOC_DPCM @uemmoz and @MDAndersonNews team to launch the PHIL study - a randomized trial of LEEP vs. Thermal Ablation in WLWH @MilaPSalcedo @MelissaLoVaron @echiaomd @JoseAJeronimo #EndCancer
Ross Harrison, MD MPH retweeted
NCT06072781 RAMP301
Great points!
🔻
▪︎LGSOC vs. HGSOC distinction
▪︎RAS-MAPK Pathway, cancer biology
▪︎The crossover rationale 📢
▪︎MEKi resensitization with FAKi
▪︎KRASm/ WT ➡️ treatment available to all-comers
▪︎Safety profile
▪︎Asia, Europe, Australia, 🇺🇸
Avutometinib Plus Defactinib Makes a Phase 3 Debut in Low-Grade Serous Ovarian Cancer @sitemancenter #gyncsm
onclive.com/view/avutometini…
Ross Harrison, MD MPH retweeted
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial - thelancet.com/journals/lance…
@TheLancet
Ross Harrison, MD MPH retweeted
NOW OF: In the single-arm, ph 2 NACI study of neoadjuvant chemotherapy plus PD-1 inhibitor camrelizumab for locally advanced cervical cancer, an objective response was noted in 83 (98% [95% CI 92–100]) of 85 patients.
#gyncsm
thelancet.com/journals/lanon…
Ross Harrison, MD MPH retweeted
✨ #JCO #ClinicalTrialUpdates: KEYNOTE-826: First-Line pembrolizumab added to chemotherapy with or without bevacizumab improves overall survival in recurrent/metastatic #CervicalCancer ➡️ brnw.ch/21wEYWO #gyncsm #ImmunoOnc
Ross Harrison, MD MPH retweeted
😞 Ofranergene obadenovec + weekly paclitaxel did not improve progression-free or overall survival compared to weekly paclitaxel alone in platinum-resistant #OvarianCancer. ➡️ brnw.ch/21wF4DR #gyncsm #ImmunoOnc
Ross Harrison, MD MPH retweeted
Our paper out in @AAGLJMIG today!
"Utility of Routine Post-Operative Exam for Detecting Vaginal Cuff Dehiscence After Total Laparoscopic Hysterectomy"
Bottom line, it doesn't do anything.
A wise attg told posed the ? "why do we assign pelvic rest ..."
sciencedirect.com/science/ar…
Ross Harrison, MD MPH retweeted
Starting January 1, health insurers will have to do more than guess. They'll have to give patients estimates of their cost for any item or service.
cms.gov/healthplan-price-tra…
Ross Harrison, MD MPH retweeted
Teamwork is essential🫸🫷
An achievement that means a lot to all of us in the #IGCSfamily #IGCS2023
Thank you for your support!🫶
@pedroramirezMD @HsuMd @JayrajAarthi @agz_eriksson @IJGCfellows @RParejaGineOnco @Frumovitz @annafagottimd @lchiv4
The International Journal of Gynecological Cancer now leads the field with the highest impact factor in #GynOnc – a clear indicator of the journal's quality and influence. Hats off to the editorial team for their rigorous work. #IJGC #IGCS2023 @pedroramirezMD @IJGConline
Ross Harrison, MD MPH retweeted
Socioeconomically vulnerable patients with #cancer have better access to the newest treatments in trials following the implementation of the ACA Medicaid Expansion ja.ma/3tJSX62
@SWOG @Fredhutch @DrJoeUnger @DrDawnHershman @riharv
Ross Harrison, MD MPH retweeted
The #CervicalCancer death rate fell across the United States from 1971 to 2015. Cervical cancer screening and the HPV vaccine save lives! NCI’s Animated Historical Cancer Atlas can show you cancer rates by state and across the US; learn more here: buff.ly/2ShY88F #GynCSM
